BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34653058)

  • 1. Non-18F-FDG-Avid Intrahepatic Metastasis of Breast Cancer Revealed by 68Ga-FAPI PET/CT.
    Wang Q; Tang W; Cai L; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):228-230. PubMed ID: 34653058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 68Ga-FAPI PET/CT Detected Non-FDG-Avid Gastric Stromal Tumor.
    Qiu L; Lan L; Liu H; Deng J; Chen Y
    Clin Nucl Med; 2022 Mar; 47(3):226-227. PubMed ID: 34392281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG.
    Shu Q; Deng M; Hu M; Liu M; Chen X; Chen Y; Cai L
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1442-1452. PubMed ID: 36609606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-FAPI Versus 18F-FDG PET/CT in Evaluating Newly Diagnosed Breast Cancer Patients: A Head-to-Head Comparative Study.
    Zheng S; Lin J; Zhu Y; Chen Y; Zhang J; Chen X; Miao W
    Clin Nucl Med; 2023 Mar; 48(3):e104-e109. PubMed ID: 36723892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 68Ga-FAPI and 18F-PET/CT Images in Intestinal Tuberculosis.
    Zheng J; Lin K; Zheng S; Yao S; Miao W
    Clin Nucl Med; 2022 Mar; 47(3):239-240. PubMed ID: 34619704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for Detecting Metastatic Lesions in a Case of Radioiodine-Refractory Differentiated Thyroid Cancer.
    Fu H; Fu J; Huang J; Pang Y; Chen H
    Clin Nucl Med; 2021 Nov; 46(11):940-942. PubMed ID: 34034326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor Imaging With 68Ga-DOTA-FAPI-04 PET/CT: Comparison With 18F-FDG PET/CT in 22 Different Cancer Types.
    Çermik TF; Ergül N; Yılmaz B; Mercanoğlu G
    Clin Nucl Med; 2022 Apr; 47(4):e333-e339. PubMed ID: 35085165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in Dermatofibrosarcoma Protuberans.
    Wu J; Zhang S; Rao Z; Wang Y; Zhang C
    Clin Nucl Med; 2022 Jul; 47(7):629-631. PubMed ID: 35452009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 18F-FDG and 68Ga-FAPI PET/CT in Gastric Kaposi Sarcoma.
    Tatar G; Beyhan E; Erol Fenercioğlu Ö; Arslan E; Çermik TF
    Clin Nucl Med; 2022 Sep; 47(9):e596-e599. PubMed ID: 35930714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of 68Ga-FAPI PET/CT for Detecting Myeloid Sarcoma of the Breast and Assessing Early Response to Chemotherapy.
    Wu S; Lin Z; Shang Q; Pang Y; Chen H
    Clin Nucl Med; 2022 Jun; 47(6):549-550. PubMed ID: 35025784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Imaging of Pancreatic Cancer With Liver Metastases.
    Deng M; Chen Y; Cai L
    Clin Nucl Med; 2021 Jul; 46(7):589-591. PubMed ID: 33630809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-FDG Versus 68Ga-FAPI PET/CT in Visualizing Primary Hepatic Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue.
    Pang Y; Zhao L; Shang Q; Meng T; Chen H
    Clin Nucl Med; 2022 Apr; 47(4):375-377. PubMed ID: 34661557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FAPI-Negative FDG-Avid Metastatic Relapse of Breast Cancer on PET/CT.
    Civan C; Has Simsek D; Isik EG; Sanli Y; Kuyumcu S
    Clin Nucl Med; 2023 Aug; 48(8):e380-e381. PubMed ID: 37220240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-FAPI Outperforms 18F-FDG PET/CT in Identifying Bone Metastasis and Peritoneal Carcinomatosis in a Patient With Metastatic Breast Cancer.
    Pang Y; Zhao L; Chen H
    Clin Nucl Med; 2020 Nov; 45(11):913-915. PubMed ID: 32910045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG and 68Ga-FAPI PET/CT in the Evaluation of Ground-Glass Opacity Nodule.
    Chen H; Pang Y; Meng T; Yu X; Sun L
    Clin Nucl Med; 2021 May; 46(5):424-426. PubMed ID: 33782300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
    Cheng Z; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2021 Sep; 46(9):764-765. PubMed ID: 34132674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-FAPI PET/CT Versus 18F-FDG PET/CT for the Evaluation of Disease Activity in Takayasu Arteritis.
    Wu S; Pang Y; Zhao L; Zhao L; Chen H
    Clin Nucl Med; 2021 Oct; 46(10):847-849. PubMed ID: 34028415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive FAPI PET/CT in a Bilateral Mammary Angiosarcoma Patient With Less Impressive FDG PET/CT Images.
    Qiu S; Zou S; Cheng S; Song S; Zhu X
    Clin Nucl Med; 2022 Jul; 47(7):648-650. PubMed ID: 35143460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Erol Fenercioğlu Ö; Beyhan E; Şahin R; Baloğlu MC; Arslan E; Çermik TF; Ergül N
    Nucl Med Commun; 2023 Oct; 44(10):896-899. PubMed ID: 37450605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of [68Ga]-FAPI PET/CT and [18F]-FDG PET/CT in Multiple Myeloma: Clinical Experience.
    Elboga U; Sahin E; Cayirli YB; Okuyan M; Aktas G; Haydaroglu Sahin H; Dogan I; Kus T; Akkurd DM; Cimen U; Mumcu V; Kilbas B; Celen YZ
    Tomography; 2022 Feb; 8(1):293-302. PubMed ID: 35202189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.